The hyper-CVAD–rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma
Title:
The hyper-CVAD–rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma
Author:
Ritchie, D. S. Seymour, J. F. Grigg, A. P. Roberts, A. W. Hoyt, R. Thompson, S. Szer, J. Prince, H. M.